Dewpoint Therapeutics
Dewpoint Therapeutics's Overview
Dewpoint Therapeutics is a leading biotechnology company translating the emerging understanding of biomolecular condensates into novel medicines for a wide range of challenging diseases. By drugging condensates, Dewpoint aims to develop breakthrough therapies for conditions where traditional drug discovery approaches have fallen short, including neurodegenerative diseases, cancer, and virology. Their proprietary platform combines advanced biology, chemistry, and AI-driven approaches to identify and optimize condensate-modifying therapeutics (c-mods).
Where is Dewpoint Therapeutics's Headquarters?
HQ Function
Primary research and development hub, corporate operations, strategic leadership, and business development.
Notable Features:
State-of-the-art laboratory facilities located in Boston's Seaport District, a vibrant innovation hub for biotechnology and life sciences. Designed to foster collaboration and cutting-edge research.
Work Culture:
Highly collaborative, science-driven, and innovative environment. Emphasis on teamwork, intellectual curiosity, and a shared mission to develop transformative medicines.
HQ Significance:
Centralizes Dewpoint's core research in condensate biology, providing access to Boston's rich ecosystem of academic institutions, biotech talent, and venture capital.
Values Reflected in HQ: Innovation, scientific rigor, collaboration, and a commitment to advancing patient care through novel therapeutic approaches.
Location:
Dewpoint Therapeutics supports its global research and development efforts through its headquarters in Boston, USA, and a significant research site in Dresden, Germany. This dual presence facilitates international collaborations, access to diverse talent pools, and advances its pioneering work in condensate-modifying therapeutics on a global scale. They also engage in strategic partnerships with global pharmaceutical companies.
Street Address:
22 Boston Wharf Road, 6th Floor
City:
Boston
State/Province:
MA
Country:
USA
Dewpoint Therapeutics's Global Presence
Dresden, Saxony, Germany
Address: Pfotenhauerstraße 108, 01307 Dresden, Germany (BioInnovationsZentrum)
Serves as a European hub for research, talent acquisition, and collaboration with EU-based academic and industry partners in the field of life sciences.
Buying Intent Signals for Dewpoint Therapeutics
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
Executive Team of Dewpoint Therapeutics
As of April 2025, Dewpoint Therapeutics' leadership includes:
Investors of Dewpoint Therapeutics
Dewpoint Therapeutics has been backed by several prominent investors over the years, including:
Executive New Hires/Exits in the Last 12 Months
Dewpoint Therapeutics has seen some key appointments in its leadership over the past 12-18 months, strengthening its scientific and operational capabilities. No prominent executive exits have been publicly announced recently.
New Appointments:
Technology (Tech Stack) used by Dewpoint Therapeutics
Discover the tools Dewpoint Therapeutics uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Dewpoint Therapeutics Email Formats and Examples
Dewpoint Therapeutics likely utilizes common corporate email formats. The most probable format is [first_initial][last]@dewpointx.com. Other possibilities include [first].[last]@dewpointx.com.
flast@dewpointx.com (e.g. jdoe@dewpointx.com)
Format
abutt@dewpointx.com
Example
85%
Success rate
News and media
Dewpoint Therapeutics Press Release • March 7, 2024
Dewpoint Therapeutics Presents Data at AD/PD™ 2024 Demonstrating Potential of Condensate Modification to Treat Tauopathies
Dewpoint shared new preclinical data on its Tau program at the AD/PD™ 2024 International Conference on Alzheimer’s and Parkinson’s Diseases, highlighting the potential of its condensate-modifying approach for neurodegenerative diseases....more
Dewpoint Therapeutics Press Release • February 27, 2024
Dewpoint Therapeutics to Present at Upcoming Investor Conferences
Dewpoint announced its participation in the TD Cowen 44th Annual Health Care Conference and the Leerink Partners Global Biopharma Conference, where CEO Aamir Butt would provide company updates....more
Dewpoint Therapeutics Press Release • January 23, 2024
Dewpoint Therapeutics Appoints Dr. Martin Seidel as Vice President, Head of Discovery and Platform
Dr. Martin Seidel joined Dewpoint to lead discovery research and further develop the company’s condensate biology platform, bringing extensive experience in drug discovery and platform technologies....more
Dewpoint Therapeutics Press Release • October 26, 2023
Dewpoint Therapeutics Presents Preclinical Data From Its Condensate Platform on Lead Program Targeting Tau Condensates for Neurodegenerative Disease at the Society for Neuroscience (SfN) 2023 Annual Meeting
Dewpoint presented preclinical data for its lead program in neurodegeneration, demonstrating target engagement and downstream effects of its c-mod targeting Tau condensates....more
Highperformr’s free tools for company research
Explore Employees by Region or Country
See where a company’s workforce is located, by country or region.
View Funding Details
View past and recent funding rounds with amounts and investors.
Understand Revenue Insights
Understand company revenue estimates and financial scale.
Track Active Job Openings
Track active roles and hiring trends to spot growth signals.
Review Product and Offerings
Discover what a company offers—products, platforms, and solutions.
Get SIC or NAICS Codes
Get the company’s official SIC and NAICS classifications.
Analyze Website Traffic Trends
Analyze visitor volume, engagement, and top traffic sources.
Discover Social Profiles and Engagement
Explore LinkedIn, Twitter, and other active social profiles.
Identify Top Competitors
Identify top competitors based on similar business traits.
Research and Discover Companies with Highperformr — Smarter, Faster
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
- Track intent signals to find buyers who are actively in-market
- Enrich contacts and companies instantly, no need to switch tools
- Automate workflows to stay ahead of every change
- Connect your CRM & tools for seamless data sync and activation
Thousands of companies, including Dewpoint Therapeutics, are just a search away.